ERBB2 and breast cancer: For instance, patients with breast cancer overexpressing HER2/neu proto-oncogene of the epidermal growth factor receptor (EGFR) family who were treated with trastuzumab/Herceptin (anti-HER2) have a high rate of brain metastases [7], [8].